The long-term ex vivo beneficial effect of p27Kip1 silencing on graft function was also indicated by the significantly higher cumulative cure rate for diabetes in mice receiving 200 targeting islets than that in mice receiving 200 non-targeting islets (P < 0.05) (Figure 4). The gene discussed is CDKN1B; the disease is diabetes mellitus.